HEALTHSEATTLE TIMES
FDA approves new pill to slash cholesterol levels
The FDA approved enlicitide (brand name Lipfendra), a daily pill that lowers cholesterol levels more effectively than statins. The drug is produced by pharmaceutical company Merck.
Related Signal
Adjacent reporting
- Merck won FDA approval for the first cholesterol pill to rival powerful injectables
- U.S. approves pill for cholesterol that drives levels down far below statins
- Full list of prescription drugs - including cholesterol-busting medication taken by millions - that could see massive price cuts under Trump's new deal
- The use of cholesterol medication may stop cancer – and more health headlines
- STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study